![Efficacy of ribavirin and interferon-α therapy for hospitalized patients with COVID-19: A multicenter, retrospective cohort study - International Journal of Infectious Diseases Efficacy of ribavirin and interferon-α therapy for hospitalized patients with COVID-19: A multicenter, retrospective cohort study - International Journal of Infectious Diseases](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/942fd660-48fd-4357-b72d-6146bfda9176/gr1.jpg)
Efficacy of ribavirin and interferon-α therapy for hospitalized patients with COVID-19: A multicenter, retrospective cohort study - International Journal of Infectious Diseases
![Community-acquired pneumonia in the emergency department: an algorithm to facilitate diagnosis and guide chest CT scan indication - Clinical Microbiology and Infection Community-acquired pneumonia in the emergency department: an algorithm to facilitate diagnosis and guide chest CT scan indication - Clinical Microbiology and Infection](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/67b256d7-36e1-4724-8e64-0476cad3f96a/gr1.jpg)
Community-acquired pneumonia in the emergency department: an algorithm to facilitate diagnosis and guide chest CT scan indication - Clinical Microbiology and Infection
![Rapid detection of bacterial infection using a novel single-tube, four-colour flow cytometric method: Comparison with PCT and CRP - EBioMedicine Rapid detection of bacterial infection using a novel single-tube, four-colour flow cytometric method: Comparison with PCT and CRP - EBioMedicine](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/bd3d02b2-eb47-4ed5-b934-21f9d40633ca/gr1.jpg)
Rapid detection of bacterial infection using a novel single-tube, four-colour flow cytometric method: Comparison with PCT and CRP - EBioMedicine
![COVID-19 in patients with rheumatic diseases in northern Italy: a single-centre observational and case–control study - The Lancet Rheumatology COVID-19 in patients with rheumatic diseases in northern Italy: a single-centre observational and case–control study - The Lancet Rheumatology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/faabd82f-a0b7-4a5e-94ed-7211adae4e48/gr1.gif)
COVID-19 in patients with rheumatic diseases in northern Italy: a single-centre observational and case–control study - The Lancet Rheumatology
![Supplemental Materials for Ceftazidime-avibactam versus meropenem in nosocomial pneumonia, including ventilator-associated pneumonia (REPROVE): a randomised, double-blind, phase 3 non-inferiority trial - The Lancet Infectious Diseases Supplemental Materials for Ceftazidime-avibactam versus meropenem in nosocomial pneumonia, including ventilator-associated pneumonia (REPROVE): a randomised, double-blind, phase 3 non-inferiority trial - The Lancet Infectious Diseases](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/18318517-4445-4a35-b4a3-ef837147d7a0/gr1.gif)
Supplemental Materials for Ceftazidime-avibactam versus meropenem in nosocomial pneumonia, including ventilator-associated pneumonia (REPROVE): a randomised, double-blind, phase 3 non-inferiority trial - The Lancet Infectious Diseases
![Anakinra in hospitalized patients with severe COVID-19 pneumonia requiring oxygen therapy: Results of a prospective, open-label, interventional study - International Journal of Infectious Diseases Anakinra in hospitalized patients with severe COVID-19 pneumonia requiring oxygen therapy: Results of a prospective, open-label, interventional study - International Journal of Infectious Diseases](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/f8e312bd-1da2-49e6-bc5b-4e311562464d/gr1.jpg)
Anakinra in hospitalized patients with severe COVID-19 pneumonia requiring oxygen therapy: Results of a prospective, open-label, interventional study - International Journal of Infectious Diseases
![Extrapulmonary CT Findings Predict In-Hospital Mortality in COVID-19. A Systematic Review and Meta-Analysis - Academic Radiology Extrapulmonary CT Findings Predict In-Hospital Mortality in COVID-19. A Systematic Review and Meta-Analysis - Academic Radiology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/e9535428-3210-464a-adac-66ee0bafe888/gr1.jpg)
Extrapulmonary CT Findings Predict In-Hospital Mortality in COVID-19. A Systematic Review and Meta-Analysis - Academic Radiology
![COVID-19 and preeclampsia with severe features at 34-weeks gestation - The American Journal of Emergency Medicine COVID-19 and preeclampsia with severe features at 34-weeks gestation - The American Journal of Emergency Medicine](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/c7ea6566-06f7-4931-8d90-47e90e06226e/gr1.jpg)
COVID-19 and preeclampsia with severe features at 34-weeks gestation - The American Journal of Emergency Medicine
![Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study - The Lancet Infectious Diseases Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study - The Lancet Infectious Diseases](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/4e3f5408-ebbb-4394-a855-f4e5d85ac5ff/gr1.jpg)
Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study - The Lancet Infectious Diseases
![Intensity Modulated Radiation Therapy Plus Etoposide/Cisplatin for Patients With Limited Advanced Unresectable Thymic Epithelial Tumors: A Prospective Phase 2 Study - International Journal of Radiation Oncology, Biology, Physics Intensity Modulated Radiation Therapy Plus Etoposide/Cisplatin for Patients With Limited Advanced Unresectable Thymic Epithelial Tumors: A Prospective Phase 2 Study - International Journal of Radiation Oncology, Biology, Physics](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/656cb31d-80e4-4512-96b5-624867cf8503/gr1.jpg)
Intensity Modulated Radiation Therapy Plus Etoposide/Cisplatin for Patients With Limited Advanced Unresectable Thymic Epithelial Tumors: A Prospective Phase 2 Study - International Journal of Radiation Oncology, Biology, Physics
![Gastrointestinal Symptoms as a Major Presentation Component of a Novel Multisystem Inflammatory Syndrome in Children That Is Related to Coronavirus Disease 2019: A Single Center Experience of 44 Cases - Gastroenterology Gastrointestinal Symptoms as a Major Presentation Component of a Novel Multisystem Inflammatory Syndrome in Children That Is Related to Coronavirus Disease 2019: A Single Center Experience of 44 Cases - Gastroenterology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/f11492fd-5d84-4c3d-b522-b3dd671fda0f/fx1.jpg)
Gastrointestinal Symptoms as a Major Presentation Component of a Novel Multisystem Inflammatory Syndrome in Children That Is Related to Coronavirus Disease 2019: A Single Center Experience of 44 Cases - Gastroenterology
![Imaging manifestations and diagnostic value of chest CT of coronavirus disease 2019 (COVID-19) in the Xiaogan area - Clinical Radiology Imaging manifestations and diagnostic value of chest CT of coronavirus disease 2019 (COVID-19) in the Xiaogan area - Clinical Radiology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/09669729-0072-434c-8cae-c459220a3891/gr1.jpg)
Imaging manifestations and diagnostic value of chest CT of coronavirus disease 2019 (COVID-19) in the Xiaogan area - Clinical Radiology
![Effect of anakinra versus usual care in adults in hospital with COVID-19 and mild-to-moderate pneumonia (CORIMUNO-ANA-1): a randomised controlled trial - The Lancet Respiratory Medicine Effect of anakinra versus usual care in adults in hospital with COVID-19 and mild-to-moderate pneumonia (CORIMUNO-ANA-1): a randomised controlled trial - The Lancet Respiratory Medicine](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/3b34b18a-9839-4bb6-bff9-3482408c39e7/gr1.gif)
Effect of anakinra versus usual care in adults in hospital with COVID-19 and mild-to-moderate pneumonia (CORIMUNO-ANA-1): a randomised controlled trial - The Lancet Respiratory Medicine
![Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study - The Lancet Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study - The Lancet](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/aa659782-3fc1-49c9-85fe-68a7a2585d80/gr1.jpg)
Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study - The Lancet
![Association between mortality and highly antimicrobial-resistant bacteria in intensive care unit-acquired pneumonia | Scientific Reports Association between mortality and highly antimicrobial-resistant bacteria in intensive care unit-acquired pneumonia | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-021-95852-4/MediaObjects/41598_2021_95852_Fig1_HTML.png)
Association between mortality and highly antimicrobial-resistant bacteria in intensive care unit-acquired pneumonia | Scientific Reports
![False negative chest X-Rays in patients affected by COVID-19 pneumonia and corresponding chest CT findings - Radiography False negative chest X-Rays in patients affected by COVID-19 pneumonia and corresponding chest CT findings - Radiography](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/bd6d9197-07b7-467c-9a47-d65139e4d8d9/gr2_lrg.jpg)
False negative chest X-Rays in patients affected by COVID-19 pneumonia and corresponding chest CT findings - Radiography
![Hospitalization for acute coronary syndrome increases the long-term risk of pneumonia: a population-based cohort study | Scientific Reports Hospitalization for acute coronary syndrome increases the long-term risk of pneumonia: a population-based cohort study | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-021-89038-1/MediaObjects/41598_2021_89038_Fig1_HTML.png)
Hospitalization for acute coronary syndrome increases the long-term risk of pneumonia: a population-based cohort study | Scientific Reports
![Lenzilumab in hospitalised patients with COVID-19 pneumonia (LIVE-AIR): a phase 3, randomised, placebo-controlled trial - The Lancet Respiratory Medicine Lenzilumab in hospitalised patients with COVID-19 pneumonia (LIVE-AIR): a phase 3, randomised, placebo-controlled trial - The Lancet Respiratory Medicine](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/b0b70c94-e206-48c3-b8e5-0319511d1f72/gr1.jpg)
Lenzilumab in hospitalised patients with COVID-19 pneumonia (LIVE-AIR): a phase 3, randomised, placebo-controlled trial - The Lancet Respiratory Medicine
![RANDGAN: Randomized generative adversarial network for detection of COVID-19 in chest X-ray | Scientific Reports RANDGAN: Randomized generative adversarial network for detection of COVID-19 in chest X-ray | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-021-87994-2/MediaObjects/41598_2021_87994_Fig1_HTML.png)